Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...

The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...

Jameela Jamil is clarifying her previous statement regarding Serena Williams and GLP-1s. Here's what she said.

Health insurance will grow more expensive in many corners of the market in 2026, and some coverage may shrink.

About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Pricey prescriptions and nagging medical costs are swamping some insurers and employers now. Patients may start paying for it next year.